Experimental peptide that affects bacterial biofilm stress responses
Preclinical research
Read the profile Peptide profile
RDP58
Experimental inhibitor of inflammatory cytokine signaling
Clinical research
Science, with its context intact.What to knowThe evidence
The evidence
in perspective.
Two early trials studied an oral formulation in ulcerative colitis. These findings do not establish broad anti-inflammatory use or current product availability.
View the supporting source- Research area
- Immune
- Biological target or mechanism
- Experimental inhibitor of inflammatory cytokine signaling
- Evidence context
- Clinical research
- Availability
- Availability requires pharmacy review
From information to a conversationClinical decisions stay
Clinical decisions stay
with clinical professionals.
This profile is a research reference. Your prescriber and pharmacy assess the relevant clinical and dispensing pathway. Inclusion here is not an offer to sell this compound.
Explore the same area.
All immune profiles
Human cathelicidin peptide with antimicrobial and immune-signaling activity
Clinical research
Read the profile